Furthermore, consistent with the SN, in the striatum, decreased expression levels of TH and DAT were also observed in the STZ-treated α-syn mice at three months after injection (Additional file 1: Fig. S2), indicating that the long-term hyperglycemia causes damage to both dopaminergic neurons and terminals in α-syn mice. The gene discussed is SLC6A3; the disease is Hyperglycemia.